Business Development

Diagnostic Partnering Opportunities

The Opportunity

Validate your discovery research on Axela’s dotLab® platform. Whether you are working with an existing marker or looking for a potential marker, the dotLab System is a cost effective and efficient way to conduct your research.

dot® technology offers :

• Rapid understanding of molecular interactions
• Very flexible format
• High sensitivity
• Broad dynamic range
• Small sample size
• Protein quantitation
• Simplified data analysis
• Multiplexing

Partnering with Axela

Axela offers partners an attractive business model to build a novel diagnostic pipeline together with a revenue generating research business. Axela is currently expanding its library of proprietary biomarker content for multiplexed research or diagnostic assays. Of particular interest are proteins that would find the greatest long term utility in point of use settings.

Existing Collaborations

Axela currently has a number of ongoing collaborations which focus on the areas outlined below:

• Cardiovascular Disease
• Oncology
• Sepsis
• Traumatic Brain Injury
• Immunology
• Screening

Contact Information

Clinical researchers and commercial partners are encouraged to contact us for further discussion. Please inquire with either: